April 15, 2020

The Immunotherapy Series, Part Two: Beyond Immunotherapy

The Immunotherapy Series, Part Two: Beyond Immunotherapy

Beyond Immunotherapy. The present and future of immune-driven medicine; toward an understanding of the immune system as the driver of solutions for treatment, prevention, and diagnosis of disease; identifying and creating responses to specific immune activation pathways.




Special guests:

Meghan Gutierrez

Chief Executive Officer

Lymphoma Research Foundation




Leo David Wang, M.D., Ph.D.

Assistant Professor, Department of Immuno-Oncology

Assistant Professor, Department of Pediatrics

City Of Hope




This series is brought to you ad-free by Adaptive Biotechnologies

See Privacy Policy at https://art19.com/privacy and California Privacy Notice at https://art19.com/privacy#do-not-sell-my-info.

Apple Podcasts podcast player iconSpotify podcast player iconYouTube podcast player iconPodcast Addict podcast player iconCastbox podcast player iconPocketCasts podcast player iconiHeartRadio podcast player iconRSS Feed podcast player icon
Apple Podcasts podcast player iconSpotify podcast player iconYouTube podcast player iconPodcast Addict podcast player iconCastbox podcast player iconPocketCasts podcast player iconiHeartRadio podcast player iconRSS Feed podcast player icon

Beyond Immunotherapy. The present and future of immune-driven medicine; toward an understanding of the immune system as the driver of solutions for treatment, prevention, and diagnosis of disease; identifying and creating responses to specific immune activation pathways.


Special guests:

Meghan Gutierrez

Chief Executive Officer

Lymphoma Research Foundation


Leo David Wang, M.D., Ph.D.

Assistant Professor, Department of Immuno-Oncology

Assistant Professor, Department of Pediatrics

City Of Hope


This series is brought to you ad-free by Adaptive Biotechnologies

See Privacy Policy at https://art19.com/privacy and California Privacy Notice at https://art19.com/privacy#do-not-sell-my-info.